Bicalutamide
Showing 26 - 50 of 240
Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)
Recruiting
- Salivary Gland Neoplasms
- Pyrotinib
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021
Prostate Adenocarcinoma, Lower Urinary Tract Symptoms Trial in Australia, New Zealand (Bicalutamide implant)
Unknown status
- Prostate Adenocarcinoma
- Lower Urinary Tract Symptoms
- Bicalutamide implant
-
Wahroonga, New South Wales, Australia
- +3 more
Jan 13, 2021
Prostatic Tumors Trial in Toronto (hypoxia measurement)
Active, not recruiting
- Prostatic Neoplasms
- hypoxia measurement
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Sep 30, 2021
Prostate Cancer Trial in Sherbrooke (Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade)
Active, not recruiting
- Prostate Cancer
- Radiotherapy 70 Gy
- +2 more
-
Sherbrooke, Quebec, CanadaCentre de Recherche Clinique du CHUS
May 20, 2022
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022
COVID-19, SARS-CoV 2 Trial in Baltimore (Bicalutamide 150 Mg Oral Tablet)
Withdrawn
- COVID-19
- SARS-CoV 2
- Bicalutamide 150 Mg Oral Tablet
-
Baltimore, MarylandJohns Hopkins Hospital
Mar 2, 2021
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)
Active, not recruiting
- Prostate Adenocarcinoma
- +4 more
- Internal Radiation Therapy
- +7 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 1, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
Prostate Cancer Trial in France (drug, procedure, radiation)
Completed
- Prostate Cancer
- bicalutamide
- +6 more
-
Angers, France
- +37 more
Jan 17, 2023
Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223
Terminated
- Prostate Cancer
- +2 more
- LHRH agonist/antagonist
- +2 more
-
Phoenix, Arizona
- +11 more
Jul 7, 2022
High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)
Recruiting
- High-risk Prostate Cancer
- Prostate Cancer
- HSV-Tk
- +5 more
-
Houston, TexasHouston Methodist Hospital
Apr 5, 2021
Prostate Cancer Trial in Toronto (drug, procedure, radiation)
Completed
- Prostate Cancer
- bicalutamide
- +4 more
-
Toronto, Ontario, CanadaToronto Sunnybrook Regional Cancer Centre
Oct 21, 2020
Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone Trial in Duarte,
Completed
- Metastatic Prostate Carcinoma
- +2 more
- Robotic Assisted Radical Prostatectomy
- +4 more
-
Duarte, California
- +2 more
Apr 7, 2021
Breast Cancer Trial in Groningen (Bicalutamide, FDHT PET)
Completed
- Breast Cancer
- Bicalutamide
- FDHT PET
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 26, 2019
Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)
Active, not recruiting
- Prostate Cancer
- Cabazitaxel
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Completed
- Prostate Cancer
- bicalutamide
- +2 more
-
Birmingham, Alabama
- +239 more
May 23, 2022
Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)
Recruiting
- Prostate Cancer
- +4 more
- PET-directed Local Therapy using Surgery
- +10 more
-
Long Beach, California
- +15 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Prostate Cancer Trial in Madison (Bicalutamide and CP-675,206 (Tremelimumab), Bicalutamide, CP-675,206 (tremelimumab),
Terminated
- Prostate Cancer
- Bicalutamide and CP-675,206 (Tremelimumab)
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 13, 2019
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- TAK-700
- Bicalutamide
-
Birmingham, Alabama
- +559 more
Dec 5, 2022